Abstract: Diabetes mellitus is a clinical condition characterized by increased blood glucose level (hyperglycemia) due to insufficient or inefficient (incompetent)insulin [1]. The incidence of diabetes is rising. As a result, Diabetic nephropathy is more common now a days and an important cause of morbidity and mortality in chronic kidney disease and end-stage kidney disease (ESKD) or failure [2]. Improved glycemic control has been demonstrated to reduce micro and macro vascular complications in patients with diabetes. Glycated hemoglobin (HbA1c) is the preferred and widely utilized biomarker of glycemic control in subjects with diabetes with higher concentrations of glucose [3].